Skip to main content
Log in

Alteplase cost saving following acute ischaemic stroke

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Yip TR, Demaerschalk BM.Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke 38: 1952-1955, No. 6, Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alteplase cost saving following acute ischaemic stroke. Pharmacoecon. Outcomes News 532, 6 (2007). https://doi.org/10.2165/00151234-200705320-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705320-00010

Keywords

Navigation